Porter Revenue, Valuation, Funding & Investors

iCarbonX is a Beijing-headquartered developer of AI-powered digital health ecosystems combining genomic sequencing, wearable data, and machine learning for personalized wellness. The platform analyzes multi-omics data from partnerships with BGI Genomics to deliver health risk scores, disease predictions, and lifestyle recommendations via mobile apps. iCarbonX focuses on chronic disease prevention through continuous monitoring of biomarkers like blood glucose and heart rate variability.

Welle is a digital health company based in New York providing personalized care plans to mitigate inflammation and chronic disease risks. Its platform uses at-home testing kits for biomarkers like hsCRP and offers nutrition, supplement, and lifestyle recommendations via app-based coaching. Welle targets corporate wellness programs and partners with employers in finance and tech sectors for employee health initiatives.

Iterative Health applies AI to gastrointestinal care through clinical trials and diagnostics. The healthcare technology company accelerates research to advance patient outcomes.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

Twin Health is a Mountain View, California-headquartered digital health company offering an AI-driven Whole Body Digital Twin platform for metabolic disorders. The system uses wearable sensors to monitor glucose, activity, and sleep, generating personalized nutrition and lifestyle plans. Clinically validated to reverse type 2 diabetes, Twin Health operates clinics in the US and India.

DXY is an online platform connecting doctors, patients, and healthcare organizations in China via specialized social media for pharmaceuticals and life sciences. Hangzhou-headquartered since 2000, it provides communication tools, public health services, and precision marketing. Backed by Tencent, Hillhouse Capital, and Legend Capital, DXY enhances medical collaboration and productivity.

Evidation Health is a San Mateo-headquartered company founded in 2012 that measures health outcomes through everyday activities via its Achievement platform. The platform enables participation in research and health programs with partners in healthcare and pharmaceuticals. Evidation maintains offices worldwide and emphasizes user-controlled health data for studies beyond clinical settings.

Truveta is a data platform formed by 13 US health systems compiling de-identified records from 70 million patients. Launched in 2021, it enables researchers in pharma and academia to query real-world evidence linking treatments to outcomes across oncology, cardiology, and neurology. Partners include Providence, Banner Health, and Sanford Health, powering 500+ studies with query results in hours versus months.

Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.

Indegene Ltd provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical device companies. It assists them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its portfolio of solutions covers all aspects of commercial, medical, regulatory, and R&D operations for life sciences companies. The company's segments include Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation, and Others. Key revenue is generated from the Omnichannel Activation segment. The company has a presence in India, Europe, and North America, with the majority of revenue coming from North America.

Cult.fit is a Bangalore-headquartered health and fitness company founded in 2016. It operates over 280 gyms across 50 Indian cities, delivering trainer-led classes in yoga, dance, strength training, and cycling. The platform provides nutrition plans via EatFit cloud kitchens, mental wellness through Cult.Mind, and primary care consultations, serving 2 million monthly active users.

JMDC Inc is engaged in constructing and providing a medical database, offering PHR and other health promotion services, telemedicine such as diagnostic imaging, and providing digital solutions to dispensing pharmacies.

MedGenome is a Bangalore-based genomics company offering next-generation sequencing diagnostics and research services for cancer, metabolic, cardiac, and rare diseases. The firm operates CLIA-certified labs in the United States and India, processing samples for over 500 hospitals and research institutions. Its platform integrates bioinformatics with population-scale data from South Asian genomes, supporting drug discovery partnerships with AstraZeneca and Bristol Myers Squibb in precision medicine initiatives.

Unite Us is a New York-headquartered platform that builds coordinated care networks linking health and social services providers. Founded in 2013, the company facilitates referrals, care tracking, and outcomes reporting across 300 communities in 30 U.S. states. Unite Us integrates with electronic health records from Epic and Cerner, serving veterans affairs, hospitals, and nonprofits focused on housing, food security, and mental health.

Dian Diagnostics Group Co Ltd is an independent third-party medical diagnostic service provider that provides diagnostic services outsourcing as its core business. It promotes the development of multi-service areas of medical diagnostic platforms and integrated development strategies for upstream and downstream industry chains, covering medical diagnostic services and diagnostic products.

OM1 is a Boston-based digital health platform that aggregates real-world data to measure patient outcomes in chronic diseases. The company analyzes longitudinal patient journeys from electronic health records, claims, and lab results covering over 300 million lives. OM1 partners with health systems, payers, and life sciences firms including AstraZeneca and Pfizer to generate evidence for value-based care. Its Real World Evidence as a Service model supports clinical trials, HEOR studies, and population health analytics. Founded in 2019, OM1 operates a cloud-based platform processing petabytes of de-identified data compliant with HIPAA and GDPR.

NantOmics is a Culver City-headquartered molecular diagnostics company that develops cloud-based molecular profiling tools, including the GPS Cancer test and OncoPlexDx Targeted Proteomic panel, to guide personalized cancer treatments for patients and oncologists. As a subsidiary of NantWorks, it delivers point-of-care insights into cancer biology through quantitative protein biomarkers and genomic profiles. NantOmics supports treatment strategies in clinical settings across the United States, with headquarters in California and integration into broader precision medicine platforms.

H1.co is a New York-based healthcare intelligence platform founded in 2017 that aggregates data on over 4 million healthcare professionals and 1,000 institutions. The service enables life sciences companies, hospitals, and health systems to access provider insights, clinical trial matching, and benchmarking tools. H1 connects stakeholders through its HCP Universe database and partners with entities like Pfizer and Mayo Clinic.